Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology
Open accessThe DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
Abstract
Liver biopsy is required when clinically important information about the diagnosis, prognosis or management of a patient cannot be obtained by safer means, or for research purposes. There are several approaches to liver biopsy but predominantly percutaneous or transvenous approaches are used. A wide choice of needles is available and the approach and type of needle used will depend on the clinical state of the patient and local expertise but, for non-lesional biopsies, a 16-gauge needle is recommended. Many patients with liver disease will have abnormal laboratory coagulation tests or receive anticoagulation or antiplatelet medication. A greater understanding of the changes in haemostasis in liver disease allows for a more rational, evidence-based approach to peri-biopsy management. Overall, liver biopsy is safe but there is a small morbidity and a very small mortality so patients must be fully counselled. The specimen must be of sufficient size for histopathological interpretation. Communication with the histopathologist, with access to relevant clinical information and the results of other investigations, is essential for the generation of a clinically useful report.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both procedures are safe with very low risk of complications [13, 14, 15].”
From Current treatment of non‐alcoholic fatty liver disease (2022) · cites this paper as [15]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AGREE II: advancing guideline development, reporting and evaluation in health care
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.090449 · Cited by 3,790
Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
Bedossa, P., Dargère, D., & Paradis, V. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.022 · Cited by 2,376
Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans
Brunetti, E., Kern, P., & Vuitton, D. A. (2010) · Acta Tropica · doi:10.1016/j.actatropica.2009.11.001 · Cited by 2,183
Rockey, D. C., Caldwell, S. H., Goodman, Z. D., Nelson, R. C., & Smith, A. D. (2009) · Hepatology · doi:10.1002/hep.22742 · Cited by 1,997
The Coagulopathy of Chronic Liver Disease
Tripodi, A., & Mannucci, P. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011170 · Cited by 1,342
Complications following percutaneous liver biopsy
Piccinino, F., Sagnelli, E., Pasquale, G., Giusti, G., Battocchia, A., Bernardi, M., Bertolazzi, R., Bianchi, F. B., Brunelli, E., Budillon, G., et al. (1986) · Journal of Hepatology · doi:10.1016/s0168-8278(86)80075-7 · Cited by 1,202
Colloredo, G., Guido, M., Sonzogni, A., & Leandro, G. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00191-0 · Cited by 869
Tripodi, A., Salerno, F., Chantarangkul, V., Clerici, M., Cazzaniga, M., Primignani, M., & Mannuccio Mannucci, P. (2005) · Hepatology · doi:10.1002/hep.20569 · Cited by 696
Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences
Lisman, T., & Porte, R. J. (2010) · Blood · doi:10.1182/blood-2010-02-261891 · Cited by 667
A 21-year experience with major hemorrhage after percutaneous liver biopsy
McGill, D. B., Rakela, J., Zinsmeister, A. R., & Ott, B. J. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91167-5 · Cited by 647
Research works printed but not linked: 2
- 10.1309/w3xcnt4hkfbn2g0b · DOI · Paper page
- 10.1111/j.1572-0241.2003.07342.x · doi:10.1111/j.1572-0241.2003.07342.x · Paper page
Cited by
Current treatment of non‐alcoholic fatty liver disease
Paternostro, R., & Trauner, M. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13531 · Cited by 305
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Vogel, A., Chan, S. L., Dawson, L. A., Kelley, R. K., Llovet, J. M., Meyer, T., Ricke, J., Rimassa, L., Sapisochin, G., Vilgrain, V., et al. (2025) · Annals of Oncology · doi:10.1016/j.annonc.2025.02.006 · Cited by 281
Non-alcoholic fatty liver disease: A patient guideline
Francque, S. M., Marchesini, G., Kautz, A., Walmsley, M., Dorner, R., Lazarus, J. V., Zelber-Sagi, S., Hallsworth, K., Busetto, L., Frühbeck, G., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100322 · Cited by 264
EASL Clinical Practice Guidelines on the management of autoimmune hepatitis
Dalekos, G., Gatselis, N., Drenth, J. P. H., Heneghan, M., Jørgensen, M., Lohse, A. W., Londoño, M., Muratori, L., Papp, M., Samyn, M., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.03.017 · Cited by 234
Liver biopsy for assessment of chronic liver diseases: a synopsis
Chowdhury, A. B., & Mehta, K. J. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00799-z · Cited by 225
Metadata
- Authors
- Neuberger, J., Patel, J., Caldwell, H., Davies, S., Hebditch, V., Hollywood, C., Hubscher, S., Karkhanis, S., Lester, W., Roslund, N., West, R., Wyatt, J. I., & Heydtmann, M.
- Affiliations
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- Royal Liverpool and Broadgreen University Hospital NHS Trust (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- British Liver Trust (GB)
- Gloucestershire Royal Hospital (GB)
- Department of Pathology, University of Birmingham, Birmingham, UK
- Queen Elizabeth Hospital Birmingham (GB)
- Patient Representative, London, UK
- St James's University Hospital (GB)
- Royal Alexandra Hospital (GB)
- Corresponding author
- Neuberger, James
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2020-05-28
- Volume
- 69
- Issue
- 8
- Pages
- 1382-1403
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC7398479
- OpenAlex
- W3032764835
- Cited by
- 449
- References
- 188
- Citations by year
- 2026: 79 · 2025: 106 · 2024: 77 · 2023: 77 · 2022: 59 · 2021: 47 · 2020: 3
- FWCI
- 33.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Gut (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by-nc)
- Apollo
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- liver biopsy, percutaneous biopsy, transvenous biopsy, biopsy needle, anticoagulation, biopsy complications, biopsy specimen adequacy, histopathological interpretation, liver disease diagnosis
- MeSH terms
- Contraindications, Procedure, Anticoagulants, Biopsy, Blood Coagulation Tests, Humans, Informed Consent, Liver, Needles, Laparoscopy, Postoperative Care, Patient Selection, Antibiotic Prophylaxis, Professional Role, Interdisciplinary Communication, Endoscopic Ultrasound-Guided Fine Needle Aspiration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. https://app.cochat.ai/papers/10.1136/gutjnl-2020-321299
- The paper
- Neuberger, J., Patel, J., Caldwell, H., Davies, S., Hebditch, V., Hollywood, C., Hubscher, S., Karkhanis, S., Lester, W., Roslund, N., West, R., Wyatt, J. I., & Heydtmann, M. (2020). Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut. https://doi.org/10.1136/gutjnl-2020-321299
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.